The Efficacy and Safety of Esketamine in Elective Laparoscopic Surgery
Clinical trial NCT06092684 · COMPLETED
Trial details
- NCT number
- NCT06092684
- Sponsor
- Chengdu Brilliant Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-20
- Primary completion
- 2024-03-19
- Enrollment
- 358
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.